EP0000745B1 - Salz eines optischen isomeren Phenyl-glycins und eines optischen isomeren 2-Aminobutanols, Verfahren zu deren Herstellung - Google Patents
Salz eines optischen isomeren Phenyl-glycins und eines optischen isomeren 2-Aminobutanols, Verfahren zu deren Herstellung Download PDFInfo
- Publication number
- EP0000745B1 EP0000745B1 EP78100531A EP78100531A EP0000745B1 EP 0000745 B1 EP0000745 B1 EP 0000745B1 EP 78100531 A EP78100531 A EP 78100531A EP 78100531 A EP78100531 A EP 78100531A EP 0000745 B1 EP0000745 B1 EP 0000745B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkoxy
- salt
- optionally substituted
- optically active
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title claims description 16
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 title 1
- -1 benzyliden Chemical group 0.000 claims description 16
- 230000003287 optical effect Effects 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000005076 adamantyloxycarbonyl group Chemical group C12(CC3CC(CC(C1)C3)C2)OC(=O)* 0.000 claims description 2
- 125000003435 aroyl group Chemical group 0.000 claims description 2
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 claims description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 claims description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 150000002367 halogens Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 4
- 238000000926 separation method Methods 0.000 description 3
- KAGSUJOTNBINKR-UHFFFAOYSA-N 2-acetamido-2-(4-methoxyphenyl)acetic acid Chemical compound COC1=CC=C(C(NC(C)=O)C(O)=O)C=C1 KAGSUJOTNBINKR-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WFRVJRZGHCTEGP-UHFFFAOYSA-N acetyl 2-acetamido-2-(4-hydroxyphenyl)acetate Chemical compound C(C)(=O)NC(C(=O)OC(C)=O)C1=CC=C(C=C1)O WFRVJRZGHCTEGP-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- SANDMWGTFWJWOL-UHFFFAOYSA-N 2-(methoxyamino)-2-phenylacetic acid Chemical compound CONC(C(O)=O)C1=CC=CC=C1 SANDMWGTFWJWOL-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- QNLQKURWPIJSJS-UHFFFAOYSA-N trimethylsilylphosphane Chemical compound C[Si](C)(C)P QNLQKURWPIJSJS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
Definitions
- the present invention relates to the separation into optical antipodes of compounds of the formula I. wherein XH, OH, C i --C 4- alkoxy, aryloxy, C 1 -C 4 -acyloxy, aralkyloxy, the optionally. is substituted with a maximum of 3 halogen atoms or nitro groups and contains a maximum of 4 carbon atoms in the alkyl radical, tert-alkoxy with a tertiary carbon atom bonded to the oxygen atom, aikoxycarbonyloxy or picolyloxycarbonyloxy and Y is aliphatic acyl, the counter.
- benzylidene may also be substituted with up to 3-halogen atoms or may contain further carbonyl groups, optionally halogen-substituted aroyl, or alkyl, alkoxy, nitro, phthalyl, trityl, optionally alkyl-, alkoxy- or halogen-substituted benzylidene, acetylisopropylidene, benzoylisopropylidene, 5,5-dimethyl-3-oxo-cyclohexen-1-yl, trichloroethyloxycarbonyl, benzyloxycarbonyl, optionally alkyl, alkoxy or halogen-substituted or substituted with a nitro group or ⁇ B (OH) 2 , tert-alkoxy with a tertiary carbon atom, which is attached to the oxygen atom, means adamantyloxycarbonyl, diphenylisopropyloxy
- optically active compounds of the formula mentioned are used as starting material for the production of semi-synthetic antibiotics of the cephalosporin or penicellin type, for example ampicillin or amoxycillin.
- the invention relates to a new process for the preparation of the optically active compounds of the above formula using optically active 2-aminobutanol.
- optically active natural amines such as cinchonidine or dehydroabiethylamine (cf. FR-A 2107926)
- these natural amines are very expensive and the separation yields are low.
- recovery of these natural amines for further use is limited because some of these amines are destroyed during the separation process, which is carried out at high temperatures.
- AT-PS 334 345 salts from optical isomers of N-acyl derivatives of dimethoxyphenylalanine and 2-aminobutanol are described. The yields are also low.
- the amino group of the amino acid or one of its derivatives is substituted in order to increase the acidity of the amino acid.
- These derivatives of the amino acids form the corresponding salts with 2-aminobutanol more easily than the amino acids themselves.
- the salts are generally prepared in water or a lower alkanol, preferably methanol, ethanol or isopropanol, one of the two salts precipitating from a racemic base Compound of formula I and optically active 2-aminobutanol can be formed.
- the method according to the invention is superior to known methods in that the op . table purity is higher than 99% and higher yields are obtained.
- amino acid derivatives are converted into the amino acids or into an amino acid which is either still substituted on the amino group or on the phenyl ring.
- the invention is illustrated by the following examples.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2735834 | 1977-08-09 | ||
| DE19772735834 DE2735834A1 (de) | 1977-08-09 | 1977-08-09 | Trennung von aminosaeuren in optische antipoden |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0000745A1 EP0000745A1 (de) | 1979-02-21 |
| EP0000745B1 true EP0000745B1 (de) | 1981-07-15 |
Family
ID=6015982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP78100531A Expired EP0000745B1 (de) | 1977-08-09 | 1978-07-28 | Salz eines optischen isomeren Phenyl-glycins und eines optischen isomeren 2-Aminobutanols, Verfahren zu deren Herstellung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4182899A (cs) |
| EP (1) | EP0000745B1 (cs) |
| JP (1) | JPS5430132A (cs) |
| AT (1) | AT359997B (cs) |
| BG (1) | BG35593A3 (cs) |
| CA (1) | CA1110653A (cs) |
| CS (1) | CS203200B2 (cs) |
| DD (1) | DD137580A5 (cs) |
| DE (2) | DE2735834A1 (cs) |
| HU (1) | HU178248B (cs) |
| IE (1) | IE47236B1 (cs) |
| IL (1) | IL55293A (cs) |
| IT (1) | IT1098014B (cs) |
| SU (1) | SU913937A3 (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985003932A1 (en) * | 1984-03-01 | 1985-09-12 | Alkaloida Vegyészeti Gyár | Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof |
| HU193199B (en) * | 1984-03-01 | 1987-08-28 | Budapesti Mueszaki Egyetem | Process for preparing optically active alpha-amino-beta-phenyl-propionic acids |
| JPH01155119A (ja) * | 1987-12-14 | 1989-06-19 | Rinnai Corp | 燃焼制御装置 |
| IT1226903B (it) * | 1988-07-12 | 1991-02-21 | Mini Ricerca Scient Tecnolog | Processo per la sintesi di aminoacidi otticamente attivi |
| FR2672593B1 (fr) * | 1991-02-08 | 1994-05-20 | Beecham Sa Laboratoires | Nouveaux composes utiles pour la resolution de la dl-n-acetyle ou la dl-n-haloacetyl-hydroxyphenylglycine. |
| US5583259A (en) * | 1991-02-08 | 1996-12-10 | Les Laboratoires Beecham S.A. | 2-(RO)-1-(R) ethylamines |
| CN102887836B (zh) * | 2011-07-18 | 2014-03-26 | 西南大学 | L-苯甘氨酸衍生物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL129419C (cs) * | 1960-08-19 | |||
| US3869505A (en) * | 1970-09-24 | 1975-03-04 | Beecham Group Ltd | DL-2-(4-hydroxyphenyl)-glycine-N,O-diacetate and salts |
| US3904681A (en) * | 1971-03-30 | 1975-09-09 | Ciba Geigy Corp | Propionic acid |
| US3796748A (en) * | 1972-08-16 | 1974-03-12 | Bristol Myers Co | Dehydroabietylammonium d-(-)-2-chloroacetylamino-2-(p-hydroxyphenyl)-acetate |
| YU36484B (en) * | 1973-06-07 | 1984-02-29 | Pliva Pharm & Chem Works | Process for preparing l-(-)-2-methyl-3-(3,4-dihydroxyphenyl)-alanine |
| JPS5069039A (cs) * | 1973-10-23 | 1975-06-09 | ||
| JPS50116434A (cs) * | 1974-03-01 | 1975-09-11 | ||
| JPS5152154A (en) * | 1974-10-26 | 1976-05-08 | Sankyo Co | nn karubometokishifuenirugurishinno kogakubunkatsuho |
-
1977
- 1977-08-09 DE DE19772735834 patent/DE2735834A1/de not_active Withdrawn
-
1978
- 1978-07-28 EP EP78100531A patent/EP0000745B1/de not_active Expired
- 1978-07-28 DE DE7878100531T patent/DE2860839D1/de not_active Expired
- 1978-08-04 BG BG040601A patent/BG35593A3/xx unknown
- 1978-08-04 DD DD78207128A patent/DD137580A5/xx unknown
- 1978-08-07 US US05/931,529 patent/US4182899A/en not_active Expired - Lifetime
- 1978-08-07 HU HU78HO2093A patent/HU178248B/hu unknown
- 1978-08-07 IL IL55293A patent/IL55293A/xx unknown
- 1978-08-07 CS CS785160A patent/CS203200B2/cs unknown
- 1978-08-07 IT IT26559/78A patent/IT1098014B/it active
- 1978-08-08 AT AT577278A patent/AT359997B/de not_active IP Right Cessation
- 1978-08-08 SU SU782645702A patent/SU913937A3/ru active
- 1978-08-08 CA CA308,911A patent/CA1110653A/en not_active Expired
- 1978-08-08 IE IE1611/78A patent/IE47236B1/en unknown
- 1978-08-09 JP JP9628578A patent/JPS5430132A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2735834A1 (de) | 1979-02-22 |
| DE2860839D1 (en) | 1981-10-22 |
| IE47236B1 (en) | 1984-01-25 |
| EP0000745A1 (de) | 1979-02-21 |
| US4182899A (en) | 1980-01-08 |
| HU178248B (en) | 1982-04-28 |
| IT1098014B (it) | 1985-08-31 |
| JPS5430132A (en) | 1979-03-06 |
| IT7826559A0 (it) | 1978-08-07 |
| IL55293A0 (en) | 1978-10-31 |
| ATA577278A (de) | 1980-05-15 |
| CS203200B2 (en) | 1981-02-27 |
| AT359997B (de) | 1980-12-10 |
| IE781611L (en) | 1979-02-09 |
| DD137580A5 (de) | 1979-09-12 |
| IL55293A (en) | 1982-09-30 |
| BG35593A3 (en) | 1984-05-15 |
| SU913937A3 (en) | 1982-03-15 |
| CA1110653A (en) | 1981-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1993010118A1 (de) | Verfahren zur trennung von 5-methyl-tetrahydrofolsäure | |
| EP0000745B1 (de) | Salz eines optischen isomeren Phenyl-glycins und eines optischen isomeren 2-Aminobutanols, Verfahren zu deren Herstellung | |
| EP0625137B1 (de) | Verfahren zur racemattrennung von verapamil | |
| EP0312726B1 (de) | Optisch aktive Salze aus einem substituierten Thiazolidin-4-carboxylat und 3-Chlor-2-hydroxypropyltrimethylammonium, deren Herstellung und Verwendung | |
| EP0237902A2 (de) | Verfahren zur Herstellung des (-)-Antipoden des (E)-1-Cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens | |
| DE2501957C2 (de) | Verfahren zur Gewinnung von optisch aktivem p-Hydroxyphenylglycin | |
| EP0126934B1 (de) | Verfahren zur Herstellung von 1,1-disubstituierten Thioharnstoffen | |
| DE2400489B2 (de) | Salze aus D- oder L-N-Methylephedrin und Enamin-Derivaten von a -Aminomonocarbonsäuren, Verfahren zu deren Herstellung und deren Verwendung | |
| DE1518337A1 (de) | Neue Roentgenkontrastmittel und Verfahren zur Herstellung derselben | |
| DE2141765A1 (de) | 4-chlor-4-thiazolin-2-one und verfahren zu deren herstellung | |
| DE69113365T2 (de) | Optisch aktives Morpholinooxobutansäure-Hydroxybinaphthalinderivat und seine Herstellung. | |
| DE2150267C3 (de) | Verfahren zur Herstellung von Peptiden | |
| DE568944C (de) | Verfahren zur Darstellung von Bis- (halogen-oxyaryl)-sulfiden | |
| DE1933187B2 (de) | Verfahren zur Herstellung von 7-Aminocephalosporansäure | |
| EP0073052B1 (de) | Verfahren zur Trennung des Racemats S-(Carboxymethyl)-(RS)-cystein (A) | |
| AT371448B (de) | Verfahren zur herstellung von neuen cis-4a-phenyl -isochinolin-derivaten und ihren saeureadditionssalzen | |
| EP0478721B1 (de) | Neue benzocycloalkencarbonsäure und verfahren zu ihrer herstellung | |
| DE869964C (de) | Verfahren zur Herstellung von Cholinderivaten | |
| DE1192209B (de) | Verfahren zur Herstellung von Estern von quaternaeren Ammoniumverbindungen | |
| DE1445692A1 (de) | Verfahren zur Herstellung von Piperazinderivaten | |
| DE1057133B (de) | Verfahren zur Herstellung neuer, pharmakologisch wirkender 1, 1-Diphenyl-2-aminoalkanole | |
| EP0315097A2 (de) | Neue Acyllabdan-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| DE2535693A1 (de) | Neue ester von pgf tief 2alpha , 15(s)-15-methyl-pgf tief 2alpha und 15(r)-15-methyl-pgf tief 2alpha | |
| DE2060217A1 (de) | Verfahren zur Herstellung von Dialkylhalogenalkylphosphinoxyden | |
| DE2154437A1 (de) | Verfahren zur Herstellung von substituierten alpha-Naphthoxyacetamiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Designated state(s): BE CH DE FR GB NL SE |
|
| 17P | Request for examination filed | ||
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Designated state(s): BE CH DE FR GB NL SE |
|
| REF | Corresponds to: |
Ref document number: 2860839 Country of ref document: DE Date of ref document: 19811022 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19840618 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840621 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19840630 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19840810 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19840930 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19850731 Year of fee payment: 8 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19860402 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19860729 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Effective date: 19860731 Ref country code: BE Effective date: 19860731 |
|
| BERE | Be: lapsed |
Owner name: HOECHST A.G. Effective date: 19860731 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19870201 |
|
| NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19870331 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
| EUG | Se: european patent has lapsed |
Ref document number: 78100531.9 Effective date: 19870505 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |